🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/01/1995 | 17,59 | 17,65 | 17,35 | 17,41 | -0,68% | 1,69% | 6.382.320 |
| 09/01/1995 | 17,77 | 17,89 | 17,53 | 17,53 | -2,00% | 2,01% | 5.727.110 |
| 06/01/1995 | 18,01 | 18,07 | 17,83 | 17,89 | -0,66% | 1,32% | 3.417.738 |
| 05/01/1995 | 18,13 | 18,19 | 18,01 | 18,01 | -0,98% | 0,99% | 2.865.022 |
| 04/01/1995 | 18,25 | 18,31 | 18,07 | 18,19 | -0,33% | 1,31% | 4.402.229 |
| 03/01/1995 | 18,13 | 18,43 | 18,07 | 18,25 | +0,33% | 1,97% | 5.817.029 |
| 30/12/1994 | 18,49 | 18,55 | 18,19 | 18,19 | -1,29% | 1,94% | 3.576.614 |
| 29/12/1994 | 18,61 | 18,61 | 18,43 | 18,43 | -0,96% | 0,96% | 3.137.083 |
| 28/12/1994 | 18,67 | 18,73 | 18,55 | 18,61 | -0,95% | 0,96% | 3.332.221 |
| 27/12/1994 | 18,73 | 18,85 | 18,67 | 18,79 | +0,32% | 0,96% | 3.526.310 |
| 23/12/1994 | 18,61 | 18,79 | 18,55 | 18,73 | +0,96% | 1,28% | 3.590.867 |
| 22/12/1994 | 18,67 | 18,79 | 18,49 | 18,55 | -0,64% | 1,60% | 4.509.334 |
| 21/12/1994 | 18,43 | 18,79 | 18,43 | 18,67 | +1,29% | 1,94% | 8.021.392 |
| 20/12/1994 | 18,25 | 18,67 | 18,25 | 18,43 | +0,98% | 2,29% | 9.754.365 |
| 19/12/1994 | 18,19 | 18,25 | 18,01 | 18,25 | +0,00% | 1,31% | 4.221.763 |
| 16/12/1994 | 18,13 | 18,31 | 17,95 | 18,25 | +1,32% | 1,97% | 10.906.746 |
| 15/12/1994 | 18,07 | 18,19 | 17,95 | 18,01 | +0,00% | 1,32% | 4.452.742 |
| 14/12/1994 | 17,89 | 18,19 | 17,89 | 18,01 | +0,00% | 1,67% | 6.263.686 |
| 13/12/1994 | 17,95 | 18,13 | 17,95 | 18,01 | +0,00% | 1,00% | 5.112.144 |
| 12/12/1994 | 17,77 | 18,01 | 17,65 | 18,01 | +1,34% | 2,01% | 4.406.211 |
| 09/12/1994 | 17,53 | 17,83 | 17,47 | 17,77 | +1,36% | 2,04% | 4.321.114 |
| 08/12/1994 | 17,89 | 17,95 | 17,47 | 17,53 | -2,33% | 2,67% | 4.907.574 |
| 07/12/1994 | 17,71 | 17,95 | 17,71 | 17,95 | +0,00% | 1,35% | 5.743.250 |
| 06/12/1994 | 17,95 | 18,19 | 17,83 | 17,95 | +0,00% | 1,99% | 9.693.162 |
| 05/12/1994 | 18,01 | 18,07 | 17,83 | 17,95 | -0,33% | 1,32% | 4.202.899 |
| 02/12/1994 | 17,65 | 18,07 | 17,59 | 18,01 | +1,68% | 2,70% | 4.597.786 |
| 01/12/1994 | 17,65 | 18,07 | 17,65 | 17,71 | -0,34% | 2,36% | 6.267.459 |
| 30/11/1994 | 17,89 | 18,07 | 17,71 | 17,77 | +0,00% | 2,00% | 8.209.194 |
| 29/11/1994 | 17,59 | 17,77 | 17,47 | 17,77 | +0,34% | 1,69% | 4.414.595 |
| 28/11/1994 | 17,47 | 17,77 | 17,47 | 17,71 | +1,36% | 1,71% | 5.197.242 |